Skip to main content

Table 1 Mortality in tumor-related status epilepticus versus status epilepticus due to another cause

From: Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis

Author Total no of patients No of tumor patients Mortality in tumor group Mortality in non-tumor group Mortality in non-tumor group, HAE excluded Type of study Setting
Amare [12] 119 13 23.1% 19.8% 18.4% Retrospective Tertiary hospital
Cavaliere [13]* 35 34 23.0% 0% 0% Retrospective University hospital
Chen [14]**# 220 17 11.8% 15.3% n/a# Prospective University hospital
DeLorenzo [7] 137 10 30.0% 36.2% 31.4% Prospective Population based
Li [15] 203 15 13.3% 16.0% 16.1% Retrospective University hospital
Rossetti [16] 96 14 21.4% 14.6% 14.6% Prospective University hospital
Scholtes [17] 236 12 16.7% 14.7% 14.8% Retrospective Hospitals and epilepsy centers
Towne [18] 253 11 36.0% 22.7% 17.5% Retrospective Hospital
Wu [19] 15601 291 15.5% 10.7% 5.8% Retrospective Population based
Total 16900 417      
Weighted averages    17.2% 11.3% 6.5%   
  1. *This study only included tumor patients; one patient had a systemic tumor without brain-metastasis. **Brain neoplasm and developmental malformation were in the same group. Separate data could not be obtained. #No separate data on hypoxic/anoxic encephalopathy were given. HAE = hypoxic/anoxic encephalopathy.